Your browser doesn't support javascript.
loading
Spinocerebellar Ataxia Type 3 Pathophysiology-Implications for Translational Research and Clinical Studies.
Stahl, Fabian; Evert, Bernd O; Han, Xinyu; Breuer, Peter; Wüllner, Ullrich.
Afiliación
  • Stahl F; German Centre for Neurodegenerative Disease (DZNE), 53127 Bonn, Germany.
  • Evert BO; Departments of Neurology and Neurodegenerative Diseases, University of Bonn, 53127 Bonn, Germany.
  • Han X; Departments of Neurology and Neurodegenerative Diseases, University of Bonn, 53127 Bonn, Germany.
  • Breuer P; Departments of Neurology and Neurodegenerative Diseases, University of Bonn, 53127 Bonn, Germany.
  • Wüllner U; German Centre for Neurodegenerative Disease (DZNE), 53127 Bonn, Germany.
Int J Mol Sci ; 25(7)2024 Apr 03.
Article en En | MEDLINE | ID: mdl-38612794
ABSTRACT
The spinocerebellar ataxias (SCA) comprise a group of inherited neurodegenerative diseases. Machado-Joseph Disease (MJD) or spinocerebellar ataxia 3 (SCA3) is the most common autosomal dominant form, caused by the expansion of CAG repeats within the ataxin-3 (ATXN3) gene. This mutation results in the expression of an abnormal protein containing long polyglutamine (polyQ) stretches that confers a toxic gain of function and leads to misfolding and aggregation of ATXN3 in neurons. As a result of the neurodegenerative process, SCA3 patients are severely disabled and die prematurely. Several screening approaches, e.g., druggable genome-wide and drug library screenings have been performed, focussing on the reduction in stably overexpressed ATXN3(polyQ) protein and improvement in the resultant toxicity. Transgenic overexpression models of toxic ATXN3, however, missed potential modulators of endogenous ATXN3 regulation. In another approach to identify modifiers of endogenous ATXN3 expression using a CRISPR/Cas9-modified SK-N-SH wild-type cell line with a GFP-T2A-luciferase (LUC) cassette under the control of the endogenous ATXN3 promotor, four statins were identified as potential activators of expression. We here provide an overview of the high throughput screening approaches yet performed to find compounds or genomic modifiers of ATXN3(polyQ) toxicity in different SCA3 model organisms and cell lines to ameliorate and halt SCA3 progression in patients. Furthermore, the putative role of cholesterol in neurodegenerative diseases (NDDs) in general and SCA3 in particular is discussed.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Machado-Joseph / Ataxias Espinocerebelosas Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Machado-Joseph / Ataxias Espinocerebelosas Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Alemania